NVST
Price
$23.46
Change
+$0.30 (+1.30%)
Updated
Oct 2, 04:59 PM (EDT)
Capitalization
3.81B
33 days until earnings call
Intraday BUY SELL Signals
PLSE
Price
$47.84
Change
-$1.99 (-3.99%)
Updated
Oct 2, 04:59 PM (EDT)
Capitalization
3.73B
45 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

NVST vs PLSE

NVST vs PLSE Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
NVST vs. PLSE commentary
Oct 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NVST is a Hold and PLSE is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
NVST vs PLSE: Fundamental Ratings
NVST
PLSE
OUTLOOK RATING
1..100
6486
VALUATION
overvalued / fair valued / undervalued
1..100
56
Fair valued
82
Overvalued
PROFIT vs RISK RATING
1..100
10047
SMR RATING
1..100
8798
PRICE GROWTH RATING
1..100
6134
P/E GROWTH RATING
1..100
82100
SEASONALITY SCORE
1..100
501

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NVST's Valuation (56) in the null industry is in the same range as PLSE (82) in the Medical Specialties industry. This means that NVST’s stock grew similarly to PLSE’s over the last 12 months.

PLSE's Profit vs Risk Rating (47) in the Medical Specialties industry is somewhat better than the same rating for NVST (100) in the null industry. This means that PLSE’s stock grew somewhat faster than NVST’s over the last 12 months.

NVST's SMR Rating (87) in the null industry is in the same range as PLSE (98) in the Medical Specialties industry. This means that NVST’s stock grew similarly to PLSE’s over the last 12 months.

PLSE's Price Growth Rating (34) in the Medical Specialties industry is in the same range as NVST (61) in the null industry. This means that PLSE’s stock grew similarly to NVST’s over the last 12 months.

NVST's P/E Growth Rating (82) in the null industry is in the same range as PLSE (100) in the Medical Specialties industry. This means that NVST’s stock grew similarly to PLSE’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NVSTPLSE
RSI
ODDS (%)
Bullish Trend 2 days ago
59%
Bearish Trend 2 days ago
83%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
67%
Bullish Trend 2 days ago
85%
Momentum
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
83%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
70%
Bearish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
71%
Bearish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 11 days ago
66%
Bullish Trend 15 days ago
88%
Declines
ODDS (%)
Bearish Trend 4 days ago
69%
Bearish Trend 2 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
67%
Bearish Trend 2 days ago
85%
Aroon
ODDS (%)
Bearish Trend 2 days ago
77%
Bullish Trend 2 days ago
88%
COMPARISON
Comparison
Oct 03, 2026
Stock price -- (NVST: $23.16 vs. PLSE: $49.83)
Brand notoriety: NVST and PLSE are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: NVST: 80% vs. PLSE: 73%
Market capitalization -- NVST: $3.81B vs. PLSE: $3.73B
NVST [@Pharmaceuticals: Other] is valued at $3.81B. PLSE’s [@Pharmaceuticals: Other] market capitalization is $3.73B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $126 to $146.54B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $8.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NVST’s FA Score shows that 0 FA rating(s) are green while PLSE’s FA Score has 0 green FA rating(s).

  • NVST’s FA Score: 0 green, 5 red.
  • PLSE’s FA Score: 0 green, 5 red.
According to our system of comparison, PLSE is a better buy in the long-term than NVST.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NVST’s TA Score shows that 4 TA indicator(s) are bullish while PLSE’s TA Score has 3 bullish TA indicator(s).

  • NVST’s TA Score: 4 bullish, 5 bearish.
  • PLSE’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, NVST is a better buy in the short-term than PLSE.

Price Growth

NVST (@Pharmaceuticals: Other) experienced а -3.78% price change this week, while PLSE (@Pharmaceuticals: Other) price change was -3.86% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -2.16%. For the same industry, the average monthly price growth was -5.15%, and the average quarterly price growth was +14.09%.

Reported Earning Dates

NVST is expected to report earnings on Nov 04, 2026.

PLSE is expected to report earnings on Nov 16, 2026.

Industries' Descriptions

@Pharmaceuticals: Other (-2.16% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

View a ticker or compare two or three
NVST
Daily Signal:
Gain/Loss:
PLSE
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
CFND3.030.03
+1.00%
C1 Fund Inc
MBOX40.230.27
+0.67%
Freedom Day Dividend ETF (MBOX)
UCON23.75N/A
+0.02%
First Trust Smith Unconstrained Bond ETF (UCON)
NCIQ15.90N/A
N/A
Hashdex Nasdaq CME Crypto Index ETF
PGRI26.46N/A
N/A
Putnam International Stock ETF (PGRI)

NVST and

Correlation & Price change

A.I.dvisor indicates that over the last year, NVST has been closely correlated with ALGN. These tickers have moved in lockstep 70% of the time. This A.I.-generated data suggests there is a high statistical probability that if NVST jumps, then ALGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVST
1D Price
Change %
NVST100%
-1.32%
ALGN - NVST
70%
Closely correlated
-0.00%
XRAY - NVST
60%
Loosely correlated
-1.35%
BIO - NVST
57%
Loosely correlated
-5.86%
A - NVST
55%
Loosely correlated
-3.27%
MTD - NVST
52%
Loosely correlated
-1.97%
More

PLSE and

Correlation & Price change

A.I.dvisor indicates that over the last year, PLSE has been loosely correlated with NVST. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if PLSE jumps, then NVST could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PLSE
1D Price
Change %
PLSE100%
-0.18%
NVST - PLSE
39%
Loosely correlated
-1.32%
CERS - PLSE
38%
Loosely correlated
-2.52%
CLPT - PLSE
32%
Poorly correlated
-6.22%
ARAY - PLSE
32%
Poorly correlated
-1.07%
TMCI - PLSE
32%
Poorly correlated
-2.48%
More